2026-10-29 17:22:36 UTC#539374newconfirmednews
IQVIA (IQV) stock news
IQVIA (IQV) stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire20 wire items
2026-10-28 19:19:00 UTC#531753newconfirmednews
JP Morgan raises IQVIA Holdings price target to $325 from $295
2026-10-28 17:10:00 UTC#530814newconfirmednews
Truist Securities maintains Buy rating on IQVIA Holdings, raises price target to $346 from $329
2026-10-28 13:27:00 UTC#529213newconfirmednews
Evercore ISI Group maintains IQVIA Holdings at Outperform, raises price target to $310 from $290
2026-10-27 21:08:16 UTC#524343duplicateconfirmednews
IQVIA Q3 revenue grows 8% to $4.43B; company notes $2.1B backlog reduction from inactive trials
2026-10-27 16:51:06 UTC#522920newconfirmednews
IQVIA issues 2026 revenue guidance of $17.35B-$17.50B and adjusted EPS of $12.90-$13.00
2026-10-27 13:31:13 UTC#521693duplicateconfirmednews
IQVIA Holdings Inc. reports Q3 2026 adjusted EPS of $3.34 on $4.43B revenue
2026-10-27 12:57:03 UTC#521444newconfirmednews
IQVIA Holdings Inc. Q3 2026 earnings call begins
2026-10-27 12:48:48 UTC#521341duplicateconfirmednews
IQVIA Q3 earnings beat driven by R&D Solutions segment
2026-10-27 11:08:02 UTC#520529newconfirmednews
IQVIA Q3 2026 Non-GAAP EPS $3.34 beats by $0.06, Revenue $4.43B beats by $60M
2026-10-27 11:01:03 UTC#520593duplicateconfirmednews
IQVIA Q3 Adjusted EPS $3.34 vs $3.28 est, Revenue $4.428B vs $4.366B est
2026-10-26 14:56:40 UTC#515518newconfirmedanalysis
IQVIA Holdings Inc. Q3 2026 Earnings Preview
2026-10-19 13:39:28 UTC#480886newconfirmedanalysis
Pharma sector accelerates AI adoption to cut R&D costs and timelines; industry reviews 2025-2026 partnerships
reutersimportance 0.40trust 0.80Pfizer Inc. +0.30PostEra, Inc. +0.30IQVIA Holdings Inc. +0.30+2 entities
2026-10-19 10:01:00 UTC#479552newconfirmednews
Global clinical trials market projected to reach USD 158.4 billion by 2033 at 7.7% CAGR, ResearchAndMarkets reports
yahooimportance 0.30trust 0.50IQVIA Holdings Inc. 0ICON plc 0Parexel International Corporation 0+2 entities
2026-10-14 11:54:00 UTC#458645newconfirmednews
Stifel maintains Buy rating on IQVIA Holdings, raises price target to $303 from $276
2026-10-07 20:19:38 UTC#428227newconfirmedpress release
IQVIA Launches AI-Powered Life Science Models to Predict Clinical Trial Outcomes
2026-10-07 18:24:00 UTC#427640newconfirmednews
Mizuho raises IQVIA Holdings price target to $300 from $275
2026-10-07 15:04:00 UTC#426590newconfirmednews
Barclays maintains Overweight rating on IQVIA Holdings
2026-09-30 12:29:00 UTC#391351newconfirmednews
UBS sets $345.00 price target on IQVIA Holdings
2026-09-29 12:43:00 UTC#384206newconfirmednews